Abstract. To examine the androgen receptor in androgen-dependent and-independent tumor immunohistochemically, an indirect immunofluorescence study with an antibody to human androgen receptor was performed. Shionogi Carcinoma 115 (SC 115) cells are an androgen-dependent mouse tumor, but the growth is sustained without androgen when fetal bovine serum is added to serum-free medium. Cells obtained from successive culture (A (-) X cells; X is generations after removal of androgen) were androgen-independent but showed binding to androgen. SC 115 cells, A (-) cells and CS 2 cells which are the other androgen-independent cells derived from SC 115, were used in the study. The androgen receptor (AR) in SC115 cells was stained as small-sized oval granules localized in the nucleus, and the number of the granules was 10-20 per cell. Removal of testosterone for one day as well as one week did not change the size of the AR, but some of the AR in A (-) 10 cells and in generations thereafter appeared to be large. Other small ones were similar to that in SC 115 cells. The nuclear location of the AR did not change in A (-) cells. The ratio of cells containing large AR to the total number of cells increased with each generation after the removal of testosterone from the culture. The addition of testosterone to the culture changed the AR in A (-) 40 cells to small ones, but did not influence the form of the AR in A (-) 60 cells. The AR in CS 2 cells had a similar appearance to that in A (-) 60 cells and did not change the form by addition of testosterone. These results suggest that AR in the functional state is small and oval in shape, and long term removal of testosterone gradually change the AR to a large one. The return of the large form of AR to a small one occurs within a limited period in the absence of androgen, but thereafter no reversibility is noticed.
SINCE human and rodent androgen receptors (ARs) were cloned [1, 2] , antibodies to AR protein have been available for immunohistochemical examination of androgen target organs [3, 4] . The relationship between the response to androgen and the status of the AR is one of the important issues in the management of human prostatic cancer. For this reason, immunohistochemical examination with an antibody to the AR has widely been performed in order to predict hormone dependency. It was reported that the number of positively stained cancer cells is related to the histological grade of human prostatic cancer, but endocrine therapy-refractory cancer tissues still contained a small amount of positively stained cells [5] [6] [7] . Thus the properties of the AR examined by the immunohistochemical method remain to be clarified, especially in androgen-unresponsive cells derived from-responsive ones.
To shed light on the status of the AR in androgen-dependent and -independent cells, the present study was aimed at examining the AR immunohistochemically.
Shionogi Carcinoma 115 (SC 115) is an androgen-dependent mouse tumor established in 1964 [8] . Cloned SC 115 cells are not able to grow in serum-free medium without testosterone, showing androgen dependency [9] [10] [11] [12] . The addition of fetal bovine serum (FBS) to the medium, however, sustains the proliferation of SC 115 cells without androgen.
After culturing without testosterone, the cells still express AR mRNA and reveal binding to androgen but grow equally in the presence and absence of testosterone, showing a loss of androgen sensitivity in relation to growth [13] .
Many immunohistochemical studies on ARs have been performed by the avidin-biotin complex method [4] [5] [6] [7] 14, 15] , but we developed an indirect fluorescence method to observe the fine structure following the report by Jenster et al. [16] and applied it to the examination of the AR in cells of SC 115 and its androgen-independent sublines.
Materials and Methods

Cells
SC 115 tumor was donated by Shionogi Laboratory in 1978 and maintained in mice of DDS strain by serial transplantation. During passages, CS 2 which grew equally in male and female mice was obtained, and thereafter was maintained in mice [17] . CS 2 was used as an androgen -independent subline containing the AR. The cloning of SC 115 and CS 2 cells was performed according to the method described in a previous report [18] . The cells were maintained in minimum essential medium/Ham' F12 (1:1, v/v) containing 10% FBS treated with 0.05% dextran-coated 0.5% charcoal (maintenance medium) with (SC 115 cells) or without (CS 2 cells) 10 nM testosterone.
To obtain other androgen-independent cells, SC 115 cells were cultured serially in maintenance medium without testosterone [13] . The cells were transferred to new dishes every one week to make a new generation. 
Discussion
There are many reports concerning antibodies to the human AR; some are polyclonal and others are monoclonal ones. Among them, the NH-27 used in the present study is a rabbit polyclonal antibody to human AR and shows a remarkedly high potency as an antibody [22] [23] [24] . NH-27 was applied to the immunohistochemical examination of AR in prostatic cancer, and clear separation of positive staining in the tissues was noticed with this antibody [14, 15] . Since there is wide homology in amino acid sequences of rodent and human ARs, in the present study NH-27 was used for immunohistochemical detection of the AR in murine tumor cells.
It was mentioned formerly that the AR moved between the cytoplasm and the nucleus in cells depending on binding with androgen. But recent studies including immunohistochemical observations have clarified exclusive nuclear localization of the AR regardless of the presence or absence of binding to androgen [25, 26] . The present study revealed nuclear localization of the AR in SC 115 cells and their sublines, and also noticed that removal of androgen did not change the localization of the AR. On the contrary, AR transfected to COS and HeLa cells localized in perinuclear lesion in the absence of androgen [16, 27] . The difference in localization may be due mainly to non-androgen target cells used as recipient cells for transfection of AR cDNA.
It is accepted that the AR binds with heat shock protein to form a large molecule when androgen is absent, and they dissociate from each other after binding with androgen [28, 29] . The present study showed that the form of the receptor in the presence of testosterone was different from that in the absence of testosterone.
It is plausible that a change in receptor size depends on binding with heat shock protein.
The AR may lose its ability to dissociate from heat shock protein after long term removal of androgen, as shown in A (-) 60 and CS 2 cells. On the other hand, it may be considered that the AR is stained as a large sized granule due to aggregation to a cluster under long removal of androgen.
In previous reports from this laboratory, CS 2 cells contained a certain amount of AR but the growth of these cells were not influenced by androgen [30] . The AR in CS 2 cells showed no mutation in DNA-and steroid-binding domains and expressed CAT (chloramphenicol acetyltrans-ferase) activity by androgen after transfection into CS 2 with CAT gene conjugated with an androgen-responsive element, showing functionally normal AR. If it be supposed that small-sized AR is functional, AR in CS 2 cells still reveals high affinity inity binding androgen and normal function due to its small size. A similar explanation is applicable to A (-) 60 cells.
Alternatively, it was reported that association of the 90 kDa heat shock protein with the AR did not affect the ligand binding ability [31, 32] . If this is applicable to SC 115 cells and their sublines, both small and large ARs in various A (-) and CS 2 cells have the ability to bind to androgen.
The presence of the AR itself is not indicative of responsiveness to androgen, since some cells unresponsive to androgen still contain AR [13, 30] . Previously it was reported that the growth of A (-) 10 cells and succeeding generations was not influenced by testosterone [13] . Thus appearance of large granules of the AR in A (-) 10 and succeeding generations was assumed to be related to the loss of response to androgen.
These results confirmed that the presence of immunological AR is not related to normal function. Considered together with the present results, the relationship between the form of the AR and function is still obscure. It is expected that immunohistochemical and biochemical studies on the AR will support the analysis of receptor function.
